Our laboratory was also the first to show that the bile acid receptor farnesoid X receptor (FXR) is expressed in breast cancer cells, that DC induced translocation of FXR into the nucleus, and that this increased the protein levels of urokinase like plasminogen activator (uPA) and its receptor [1]. Here, NR1H4 is linked to breast carcinoma.